Search

Getting started in research

Dave had a passion for research and was very encouraging in developing a research interest in others. Bhavisha and Amanda are currently working with a team of researchers, patients, research funders, the Department of Health and Social Care and NHS England, to develop the 2023-2028 UK Action Plan for Hearing loss and Tinnitus Research - a set of recommendations to grow hearing research in the UK. Here, they discuss their journey to hearing care research and how you could get involved in the world of research.

Jameel Muzaffar, Anne Schilder and James O’Hara

In a follow-up to the interview with Anne Schilder back in 2016*, Jameel Muzaffar speaks to Anne and to James O’Hara about the current research landscape in ENT in the UK. *Banerjee A. In conversation with Professor Anne Schilder. ENT...

Imaging and management of head and neck vascular anomalies

Vascular anomalies are a diffuse spectrum of abnormalities which often involve the head, neck and oral cavity. They are frequently misnamed, often being generically labelled as haemangiomas. This lack of basic understanding can cause confusion leading to a cascade of...

OBITUARY: Dr David Pothier

David Pothier passed away on July 27, 2018 in the early hours of the morning following a struggle with recurrent brain cancer. His passing extinguished a brilliant light, the likes of which few of us will witness in our lifetime....

OTC hearing aids

The potential for the deregulation of hearing aid technology, through the Over-The-Counter Act has led to a tremendous amount of opinions and views from all stakeholders in the US. You don’t have to go far on the internet, social media...

Experience on the front line

21st January 2021 Back to basics Yesterday I went right back to where my medical career began. I grew up in Germany, bilingual. A prerequisite to studying medicine in Germany is that applicants have to spend two months working as...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

The future of inner ear drug delivery

The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...